Risk profile of individuals who provide assistance with illicit drug injections

Drug and Alcohol Dependence

Volumn 82, Issue 1, 2006, Pages 41-46

  Fairbairn, Nadia ^a   Wood, Evan ^a,b   Small, Will ^a   Stoltz, Jo Anne ^a   Li, Kathy ^a   Kerr, Thomas ^a  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Assisted injection; Harm reduction; Hit doctors; HIV; Injection drug use; Vancouver

Indexed keywords

COCAINE; DIAMORPHINE; ILLICIT DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG USE; FEMALE; HARM REDUCTION; HUMAN; HUMAN RELATION; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SOCIAL INTERACTION; STATISTICAL ANALYSIS; SYRINGE;

ADULT; CANADA; COMMERCE; FEMALE; HARM REDUCTION; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33344456350     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2005.08.007     Document Type: Article

References (22)

1. M. Backmund, K. Meyer, M. Von Zielonka, and D. Eichenlaub Treatment of hepatitis C infection in injection drug users Hepatology 34 2001 188 193
2. K.J. Craib, P.M. Spittal, E. Wood, N. Laliberte, R.S. Hogg, K. Li, K. Heath, M.W. Tyndall, M.V. O'Shaughnessy, and M.T. Schechter Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver CMAJ 7 2003 19 24
3. N. Crofts, D. Jolley, J. Kaldor, I. van Beek, and A. Wodak Epidemiology of hepatitis C virus infection among injecting drug users in Australia J Epidemiol Community Health 51 1997 692 697
4. S.R. Friedman, R.T. Furst, B. Jose, R. Curtis, A. Neaigus, D.C. Des Jarlais, M.F. Goldstein, and D.F. Ildefonso Drug scene roles and HIV risk Addiction 93 1998 1403 1416
5. S.R. Friedman, S.Y. Kang, S. Deren, R. Robles, H.M. Colon, J. Andia, D. Oliver-Velez, and A. Finlinson Drug-scene roles and HIV risk among Puerto Rican injection drug users in East Harlem, New York and Bayamon Puerto Rico J Psychoactive Drugs 34 2002 363 369
6. C.L. Fry Safer injecting facilities in Vancouver: considering issues beyond potential use CMAJ 169 2003 777 778
7. N. Galai, M. Safaeian, D. Vlahov, A. Bolotin, and D.D. Celentano Longitudinal patterns of drug injection behavior in the ALIVE Study cohort 1988-2000: description and determinants Am J Epidemiol 158 2003 695 704
8. H. Hagan, H. Thiede, N.S. Weiss, S.G. Hopkins, J.S. Duchin, and E.R. Alexander Sharing of drug preparation equipment as a risk factor for hepatitis C Am J Public Health 91 2001 42 46
9. T. Kerr, M. Oleson, M.W. Tyndall, J.S. Montaner, and E. Wood An evaluation of a peer-run safer injection site for injection drug users J Urban Health 82 2005 267 275
10. T. Kerr, M. Tyndall, K. Li, J. Montaner, and E. Wood Safer injection facility use and syringe sharing among a cohort of injection drug users Lancet 366 2005 316 318
11. T. Kerr, E. Wood, D. Small, A. Palepu, and M.W. Tyndall Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside CMAJ 169 2003 759 763
12. D. Kitayaporn, C. Uneklabh, B.G. Weniger, P. Lohsomboon, J. Kaewkungwal, W.M. Morgan, and T. Uneklabh HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand AIDS 8 1994 1443 1450
13. A.H. Kral, R.N. Bluthenthal, E.A. Erringer, J. Lorvick, and B.R. Edlin Risk factors among IDUs who give injections to or receive injections from other drug users Addiction 94 1999 675 683
14. A.H. Kral, R.N. Bluthenthal, J. Lorvick, L. Gee, P. Bacchetti, and B.R. Edlin Sexual transmission of HIV-1 among injection drug users in San Francisco USA: risk-factor analysis Lancet 357 2001 1397 1401
15. P. Maggi, M. Fullone, M. Federico, G. Angarano, G. Pastore, and G. Regina Drug injection in jugular veins: a new risk factor for vascular diseases in HIV-infected patients? A case report Angiology 46 1995 1049 1052
16. MSIC Evaluation Committee. Final report of the Sydney medically supervised injecting centre. Sydney: MSIC Evaluation Committee, 2003.
17. J. O'Connell, T. Kerr, M.W. Tyndall, K. Li, R. Hogg, J. Montaner, M. O'Shaughnessy, M. Schechter, and E. Wood Requiring help injecting independently predicts incident HIV infection among injection drug users J Acquir Immune Defic Syndr 40 2005 83 88
18. M.W. Tyndall, S. Currie, P. Spittal, K. Li, E. Wood, M.V. O'Shaughnessy, and M.T. Schechter Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic AIDS 17 2003 887 893
19. E. Wood, T. Kerr, J.S. Montaner, S.A. Strathdee, A. Wodak, C.A. Hankins, M.T. Schechter, and M.W. Tyndall Rationale for evaluating North America's first medically supervised safer injecting facility Lancet Infect Dis 4 2004 301 306
20. E. Wood, P.M. Spittal, T. Kerr, W. Small, M.W. Tyndall, M.V. O'Shaughnessy, and M.T. Schechter Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: Implications for HIV prevention Can J Public Health 94 2003 355 359
21. E. Wood, M.W. Tyndall, P.M. Spittal, K. Li, R.S. Hogg, J.S. Montaner, M.V. O'Shaughnessy, and M.T. Schechter Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme AIDS 16 2002 941 943
22. E. Wood, M.W. Tyndall, P.M. Spittal, K. Li, T. Kerr, R.S. Hogg, J.S. Montaner, M.V. O'Shaughnessy, and M.T. Schechter Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? CMAJ 165 2001 405 410